Pharma & Healthcare
Global Inhaled Nitric Oxide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307490
- Pages: 118
- Figures: 117
- Views: 2
In 2024, the global market size of Inhaled Nitric Oxide was estimated to be worth US$ 1270 million and is forecast to reach approximately US$ 2202 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.
North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.
In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.
The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Segment by Type
800 ppm
100 ppm
Others
Segment by Application
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Inhaled Nitric Oxide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhaled Nitric Oxide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.
North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.
In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.
The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Segment by Type
800 ppm
100 ppm
Others
Segment by Application
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Inhaled Nitric Oxide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhaled Nitric Oxide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Inhaled Nitric Oxide Product Introduction
1.2 Market by Type
1.2.1 Global Inhaled Nitric Oxide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 Market by Application
1.3.1 Global Inhaled Nitric Oxide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Near-term and Pre-term Infants PPHN
1.3.3 Children and Adult ARDS
1.3.4 Other Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts
2.1.1 Global Inhaled Nitric Oxide Revenue 2020-2031
2.1.2 Global Inhaled Nitric Oxide Sales 2020-2031
2.2 Inhaled Nitric Oxide Market Size by Region: 2024 Versus 2031
2.3 Inhaled Nitric Oxide Sales by Region (2020-2031)
2.3.1 Global Inhaled Nitric Oxide Sales by Region: 2020-2025
2.3.2 Global Inhaled Nitric Oxide Sales Forecast by Region (2026-2031)
2.3.3 Global Inhaled Nitric Oxide Sales Market Share by Region (2020-2031)
2.4 Inhaled Nitric Oxide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Inhaled Nitric Oxide Revenue by Region: 2020-2025
2.4.2 Global Inhaled Nitric Oxide Revenue Forecast by Region (2026-2031)
2.4.3 Global Inhaled Nitric Oxide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Inhaled Nitric Oxide Sales by Type (2020-2031)
3.1.1.1 Global Inhaled Nitric Oxide Sales Volume by Type (2020-2031)
3.1.1.2 Global Inhaled Nitric Oxide Sales Market Share by Type (2020-2031)
3.1.2 Global Inhaled Nitric Oxide Revenue by Type (2020-2031)
3.1.2.1 Global Inhaled Nitric Oxide Revenue by Type (2020-2031)
3.1.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Type (2020-2031)
3.1.3 Inhaled Nitric Oxide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Inhaled Nitric Oxide Sales by Application (2020-2031)
3.2.1.1 Global Inhaled Nitric Oxide Sales Volume by Application (2020-2031)
3.2.1.2 Global Inhaled Nitric Oxide Sales Market Share by Application (2020-2031)
3.2.2 Global Inhaled Nitric Oxide Revenue by Application (2020-2031)
3.2.2.1 Global Inhaled Nitric Oxide Revenue by Application (2020-2031)
3.2.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Application (2020-2031)
3.2.3 Inhaled Nitric Oxide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 800 ppm of Inhaled Nitric Oxide Revenue Market Share by Application
3.3.2 100 ppm of Inhaled Nitric Oxide Revenue Market Share by Application
3.3.3 Others of Inhaled Nitric Oxide Revenue Market Share by Application
4 Global Inhaled Nitric Oxide by Manufacturers
4.1 Global Top Inhaled Nitric Oxide Manufacturers by Sales (2020-2025)
4.1.1 Global Inhaled Nitric Oxide Sales by Manufacturer (2020-2025)
4.1.2 Global Inhaled Nitric Oxide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Inhaled Nitric Oxide Manufacturers by Revenue (2020-2025)
4.2.1 Global Inhaled Nitric Oxide Revenue by Manufacturer (2020-2025)
4.2.2 Global Inhaled Nitric Oxide Revenue Share by Manufacturer (2020-2025)
4.3 Global Inhaled Nitric Oxide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Inhaled Nitric Oxide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Inhaled Nitric Oxide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Inhaled Nitric Oxide Manufacturing Base Distribution, Product Type
4.5.1 Inhaled Nitric Oxide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Inhaled Nitric Oxide Market
4.5.3 Manufacturers Inhaled Nitric Oxide Product Type and Application
4.5.4 800 ppm Market Sales of Inhaled Nitric Oxide by Manufacturer
4.5.5 100 ppm Market Sales of Inhaled Nitric Oxide by Manufacturer
4.5.6 Others Market Sales of Inhaled Nitric Oxide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Mallinckrodt
5.1.1 Mallinckrodt Company Information
5.1.2 Mallinckrodt Description, Business Overview
5.1.3 Mallinckrodt Inhaled Nitric Oxide Products Offered
5.1.4 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Mallinckrodt Inhaled Nitric Oxide Sales by Product in 2024
5.1.6 Mallinckrodt Inhaled Nitric Oxide Sales by Application in 2024
5.1.7 Mallinckrodt Inhaled Nitric Oxide Sales by Geographic Area in 2024
5.1.8 Mallinckrodt Recent Developments
5.2 Praxair (Linde plc)
5.2.1 Praxair (Linde plc) Company Information
5.2.2 Praxair (Linde plc) Description, Business Overview
5.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Products Offered
5.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Product in 2024
5.2.6 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Application in 2024
5.2.7 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Geographic Area in 2024
5.2.8 Praxair (Linde plc) Recent Developments
5.3 Air Liquide
5.3.1 Air Liquide Company Information
5.3.2 Air Liquide Description, Business Overview
5.3.3 Air Liquide Inhaled Nitric Oxide Products Offered
5.3.4 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Air Liquide Inhaled Nitric Oxide Sales by Product in 2024
5.3.6 Air Liquide Inhaled Nitric Oxide Sales by Application in 2024
5.3.7 Air Liquide Inhaled Nitric Oxide Sales by Geographic Area in 2024
5.3.8 Air Liquide Recent Developments
5.4 BOC Healthcare (Linde Group)
5.4.1 BOC Healthcare (Linde Group) Company Information
5.4.2 BOC Healthcare (Linde Group) Description, Business Overview
5.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Products Offered
5.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Product in 2024
5.4.6 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Application in 2024
5.4.7 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Geographic Area in 2024
5.4.8 BOC Healthcare (Linde Group) Recent Developments
6 North America
6.1 North America Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
6.2 North America Inhaled Nitric Oxide Market Facts & Figures by Country
6.2.1 North America Inhaled Nitric Oxide Sales by Country (2020-2031)
6.2.2 North America Inhaled Nitric Oxide Revenue by Country (2020-2031)
6.3 North America Inhaled Nitric Oxide Sales by Type (2020-2025)
6.4 North America Inhaled Nitric Oxide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Inhaled Nitric Oxide Market Facts & Figures by Region
7.2.1 Asia-Pacific Inhaled Nitric Oxide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Inhaled Nitric Oxide Revenue by Region (2020-2031)
7.3 Asia-Pacific Inhaled Nitric Oxide Sales by Type (2020-2025)
7.4 Asia-Pacific Inhaled Nitric Oxide Sales by Application (2020-2025)
8 Europe
8.1 Europe Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
8.2 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
8.2.1 Europe Inhaled Nitric Oxide Sales by Country (2020-2031)
8.2.2 Europe Inhaled Nitric Oxide Revenue by Country (2020-2031)
8.3 Europe Inhaled Nitric Oxide Sales by Type (2020-2025)
8.4 Europe Inhaled Nitric Oxide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
9.2 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
9.2.1 Latin America Inhaled Nitric Oxide Sales by Country (2020-2031)
9.2.2 Latin America Inhaled Nitric Oxide Revenue by Country (2020-2031)
9.3 Latin America Inhaled Nitric Oxide Sales by Type (2020-2025)
9.4 Latin America Inhaled Nitric Oxide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
10.2.1 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2020-2031)
10.3 Middle East and Africa Inhaled Nitric Oxide Sales by Type (2020-2025)
10.4 Middle East and Africa Inhaled Nitric Oxide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Inhaled Nitric Oxide Supply Chain Analysis
11.2 Inhaled Nitric Oxide Key Raw Materials and Upstream Suppliers
11.3 Inhaled Nitric Oxide Clients Analysis
11.4 Inhaled Nitric Oxide Sales Channel and Sales Model Analysis
11.4.1 Inhaled Nitric Oxide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Inhaled Nitric Oxide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Inhaled Nitric Oxide Distributors
12 Inhaled Nitric Oxide Market Dynamics
12.1 Inhaled Nitric Oxide Industry Trends
12.2 Inhaled Nitric Oxide Market Drivers
12.3 Inhaled Nitric Oxide Market Challenges
12.4 Inhaled Nitric Oxide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Inhaled Nitric Oxide Product Introduction
1.2 Market by Type
1.2.1 Global Inhaled Nitric Oxide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 Market by Application
1.3.1 Global Inhaled Nitric Oxide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Near-term and Pre-term Infants PPHN
1.3.3 Children and Adult ARDS
1.3.4 Other Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts
2.1.1 Global Inhaled Nitric Oxide Revenue 2020-2031
2.1.2 Global Inhaled Nitric Oxide Sales 2020-2031
2.2 Inhaled Nitric Oxide Market Size by Region: 2024 Versus 2031
2.3 Inhaled Nitric Oxide Sales by Region (2020-2031)
2.3.1 Global Inhaled Nitric Oxide Sales by Region: 2020-2025
2.3.2 Global Inhaled Nitric Oxide Sales Forecast by Region (2026-2031)
2.3.3 Global Inhaled Nitric Oxide Sales Market Share by Region (2020-2031)
2.4 Inhaled Nitric Oxide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Inhaled Nitric Oxide Revenue by Region: 2020-2025
2.4.2 Global Inhaled Nitric Oxide Revenue Forecast by Region (2026-2031)
2.4.3 Global Inhaled Nitric Oxide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Inhaled Nitric Oxide Sales by Type (2020-2031)
3.1.1.1 Global Inhaled Nitric Oxide Sales Volume by Type (2020-2031)
3.1.1.2 Global Inhaled Nitric Oxide Sales Market Share by Type (2020-2031)
3.1.2 Global Inhaled Nitric Oxide Revenue by Type (2020-2031)
3.1.2.1 Global Inhaled Nitric Oxide Revenue by Type (2020-2031)
3.1.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Type (2020-2031)
3.1.3 Inhaled Nitric Oxide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Inhaled Nitric Oxide Sales by Application (2020-2031)
3.2.1.1 Global Inhaled Nitric Oxide Sales Volume by Application (2020-2031)
3.2.1.2 Global Inhaled Nitric Oxide Sales Market Share by Application (2020-2031)
3.2.2 Global Inhaled Nitric Oxide Revenue by Application (2020-2031)
3.2.2.1 Global Inhaled Nitric Oxide Revenue by Application (2020-2031)
3.2.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Application (2020-2031)
3.2.3 Inhaled Nitric Oxide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 800 ppm of Inhaled Nitric Oxide Revenue Market Share by Application
3.3.2 100 ppm of Inhaled Nitric Oxide Revenue Market Share by Application
3.3.3 Others of Inhaled Nitric Oxide Revenue Market Share by Application
4 Global Inhaled Nitric Oxide by Manufacturers
4.1 Global Top Inhaled Nitric Oxide Manufacturers by Sales (2020-2025)
4.1.1 Global Inhaled Nitric Oxide Sales by Manufacturer (2020-2025)
4.1.2 Global Inhaled Nitric Oxide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Inhaled Nitric Oxide Manufacturers by Revenue (2020-2025)
4.2.1 Global Inhaled Nitric Oxide Revenue by Manufacturer (2020-2025)
4.2.2 Global Inhaled Nitric Oxide Revenue Share by Manufacturer (2020-2025)
4.3 Global Inhaled Nitric Oxide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Inhaled Nitric Oxide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Inhaled Nitric Oxide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Inhaled Nitric Oxide Manufacturing Base Distribution, Product Type
4.5.1 Inhaled Nitric Oxide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Inhaled Nitric Oxide Market
4.5.3 Manufacturers Inhaled Nitric Oxide Product Type and Application
4.5.4 800 ppm Market Sales of Inhaled Nitric Oxide by Manufacturer
4.5.5 100 ppm Market Sales of Inhaled Nitric Oxide by Manufacturer
4.5.6 Others Market Sales of Inhaled Nitric Oxide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Mallinckrodt
5.1.1 Mallinckrodt Company Information
5.1.2 Mallinckrodt Description, Business Overview
5.1.3 Mallinckrodt Inhaled Nitric Oxide Products Offered
5.1.4 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Mallinckrodt Inhaled Nitric Oxide Sales by Product in 2024
5.1.6 Mallinckrodt Inhaled Nitric Oxide Sales by Application in 2024
5.1.7 Mallinckrodt Inhaled Nitric Oxide Sales by Geographic Area in 2024
5.1.8 Mallinckrodt Recent Developments
5.2 Praxair (Linde plc)
5.2.1 Praxair (Linde plc) Company Information
5.2.2 Praxair (Linde plc) Description, Business Overview
5.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Products Offered
5.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Product in 2024
5.2.6 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Application in 2024
5.2.7 Praxair (Linde plc) Inhaled Nitric Oxide Sales by Geographic Area in 2024
5.2.8 Praxair (Linde plc) Recent Developments
5.3 Air Liquide
5.3.1 Air Liquide Company Information
5.3.2 Air Liquide Description, Business Overview
5.3.3 Air Liquide Inhaled Nitric Oxide Products Offered
5.3.4 Air Liquide Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Air Liquide Inhaled Nitric Oxide Sales by Product in 2024
5.3.6 Air Liquide Inhaled Nitric Oxide Sales by Application in 2024
5.3.7 Air Liquide Inhaled Nitric Oxide Sales by Geographic Area in 2024
5.3.8 Air Liquide Recent Developments
5.4 BOC Healthcare (Linde Group)
5.4.1 BOC Healthcare (Linde Group) Company Information
5.4.2 BOC Healthcare (Linde Group) Description, Business Overview
5.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Products Offered
5.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Product in 2024
5.4.6 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Application in 2024
5.4.7 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales by Geographic Area in 2024
5.4.8 BOC Healthcare (Linde Group) Recent Developments
6 North America
6.1 North America Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
6.2 North America Inhaled Nitric Oxide Market Facts & Figures by Country
6.2.1 North America Inhaled Nitric Oxide Sales by Country (2020-2031)
6.2.2 North America Inhaled Nitric Oxide Revenue by Country (2020-2031)
6.3 North America Inhaled Nitric Oxide Sales by Type (2020-2025)
6.4 North America Inhaled Nitric Oxide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Inhaled Nitric Oxide Market Facts & Figures by Region
7.2.1 Asia-Pacific Inhaled Nitric Oxide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Inhaled Nitric Oxide Revenue by Region (2020-2031)
7.3 Asia-Pacific Inhaled Nitric Oxide Sales by Type (2020-2025)
7.4 Asia-Pacific Inhaled Nitric Oxide Sales by Application (2020-2025)
8 Europe
8.1 Europe Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
8.2 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
8.2.1 Europe Inhaled Nitric Oxide Sales by Country (2020-2031)
8.2.2 Europe Inhaled Nitric Oxide Revenue by Country (2020-2031)
8.3 Europe Inhaled Nitric Oxide Sales by Type (2020-2025)
8.4 Europe Inhaled Nitric Oxide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
9.2 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
9.2.1 Latin America Inhaled Nitric Oxide Sales by Country (2020-2031)
9.2.2 Latin America Inhaled Nitric Oxide Revenue by Country (2020-2031)
9.3 Latin America Inhaled Nitric Oxide Sales by Type (2020-2025)
9.4 Latin America Inhaled Nitric Oxide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Inhaled Nitric Oxide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
10.2.1 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2020-2031)
10.3 Middle East and Africa Inhaled Nitric Oxide Sales by Type (2020-2025)
10.4 Middle East and Africa Inhaled Nitric Oxide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Inhaled Nitric Oxide Supply Chain Analysis
11.2 Inhaled Nitric Oxide Key Raw Materials and Upstream Suppliers
11.3 Inhaled Nitric Oxide Clients Analysis
11.4 Inhaled Nitric Oxide Sales Channel and Sales Model Analysis
11.4.1 Inhaled Nitric Oxide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Inhaled Nitric Oxide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Inhaled Nitric Oxide Distributors
12 Inhaled Nitric Oxide Market Dynamics
12.1 Inhaled Nitric Oxide Industry Trends
12.2 Inhaled Nitric Oxide Market Drivers
12.3 Inhaled Nitric Oxide Market Challenges
12.4 Inhaled Nitric Oxide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Inhaled Nitric Oxide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Inhaled Nitric Oxide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Inhaled Nitric Oxide Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 5. Global Inhaled Nitric Oxide Sales Forecast by Region (2026-2031) & (M L)
Table 6. Global Inhaled Nitric Oxide Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Inhaled Nitric Oxide Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Inhaled Nitric Oxide Sales Volume by Type (2020-2025) & (M L)
Table 9. Global Inhaled Nitric Oxide Sales Volume by Type (2026-2031) & (M L)
Table 10. Global Inhaled Nitric Oxide Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Inhaled Nitric Oxide Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Inhaled Nitric Oxide Sales Volume by Application (2020-2025) & (M L)
Table 13. Global Inhaled Nitric Oxide Sales Volume by Application (2026-2031) & (M L)
Table 14. Global Inhaled Nitric Oxide Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Inhaled Nitric Oxide Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Inhaled Nitric Oxide Sales by Manufacturer (2020-2025) & (M L)
Table 17. Global Inhaled Nitric Oxide Sales Share by Manufacturer (2020-2025)
Table 18. Inhaled Nitric Oxide Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Inhaled Nitric Oxide Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Inhaled Nitric Oxide Price (2020-2025) & (US$/L)
Table 21. Ranking of Global Top Inhaled Nitric Oxide Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Inhaled Nitric Oxide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Inhaled Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
Table 24. Inhaled Nitric Oxide Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Inhaled Nitric Oxide Market
Table 26. Manufacturers Inhaled Nitric Oxide Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Mallinckrodt Company Information
Table 29. Mallinckrodt Description and Business Overview
Table 30. Mallinckrodt Inhaled Nitric Oxide Product
Table 31. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 32. Mallinckrodt Sales Proportion of Inhaled Nitric Oxide by Product in 2024
Table 33. Mallinckrodt Sales Proportion of Inhaled Nitric Oxide by Application in 2024
Table 34. Mallinckrodt Sales Proportion of Inhaled Nitric Oxide by Geographic Area in 2024
Table 35. Mallinckrodt Recent Developments
Table 36. Praxair (Linde plc) Company Information
Table 37. Praxair (Linde plc) Description and Business Overview
Table 38. Praxair (Linde plc) Inhaled Nitric Oxide Product
Table 39. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 40. Praxair (Linde plc) Sales Proportion of Inhaled Nitric Oxide by Product in 2024
Table 41. Praxair (Linde plc) Sales Proportion of Inhaled Nitric Oxide by Application in 2024
Table 42. Praxair (Linde plc) Sales Proportion of Inhaled Nitric Oxide by Geographic Area in 2024
Table 43. Praxair (Linde plc) Recent Developments
Table 44. Air Liquide Company Information
Table 45. Air Liquide Description and Business Overview
Table 46. Air Liquide Inhaled Nitric Oxide Product
Table 47. Air Liquide Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 48. Air Liquide Sales Proportion of Inhaled Nitric Oxide by Product in 2024
Table 49. Air Liquide Sales Proportion of Inhaled Nitric Oxide by Application in 2024
Table 50. Air Liquide Sales Proportion of Inhaled Nitric Oxide by Geographic Area in 2024
Table 51. Air Liquide Recent Developments
Table 52. BOC Healthcare (Linde Group) Company Information
Table 53. BOC Healthcare (Linde Group) Description and Business Overview
Table 54. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product
Table 55. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 56. BOC Healthcare (Linde Group) Sales Proportion of Inhaled Nitric Oxide by Product in 2024
Table 57. BOC Healthcare (Linde Group) Sales Proportion of Inhaled Nitric Oxide by Application in 2024
Table 58. BOC Healthcare (Linde Group) Sales Proportion of Inhaled Nitric Oxide by Geographic Area in 2024
Table 59. BOC Healthcare (Linde Group) Recent Developments
Table 60. North America Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 61. North America Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 62. North America Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 63. North America Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 64. North America Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 65. North America Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 66. Asia-Pacific Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 67. Asia-Pacific Inhaled Nitric Oxide Sales by Region (2026-2031) & (M L)
Table 68. Asia-Pacific Inhaled Nitric Oxide Revenue by Region (2020-2025) & (US$ Million)
Table 69. Asia-Pacific Inhaled Nitric Oxide Revenue by Region (2026-2031) & (US$ Million)
Table 70. Asia-Pacific Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 71. Asia-Pacific Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 72. Europe Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 73. Europe Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 74. Europe Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 75. Europe Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 76. Europe Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 77. Europe Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 78. Latin America Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 79. Latin America Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 80. Latin America Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 81. Latin America Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 82. Latin America Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 83. Latin America Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 84. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 85. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 86. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 87. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 88. Middle East and Africa Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 89. Middle East and Africa Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 90. Inhaled Nitric Oxide Key Raw Materials, Industry Status and Trend
Table 91. Inhaled Nitric Oxide Key Raw Materials and Upstream Suppliers
Table 92. Inhaled Nitric Oxide Clients Status and Trend
Table 93. Inhaled Nitric Oxide Typical Clients
Table 94. Inhaled Nitric Oxide Distributors
Table 95. Inhaled Nitric Oxide Market Trends
Table 96. Inhaled Nitric Oxide Market Drivers
Table 97. Inhaled Nitric Oxide Market Challenges
Table 98. Inhaled Nitric Oxide Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Inhaled Nitric Oxide Product Picture
Figure 2. Global Inhaled Nitric Oxide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Inhaled Nitric Oxide Sales Market Share by Type in 2024 & 2031
Figure 4. 800 ppm Product Picture
Figure 5. 100 ppm Product Picture
Figure 6. Others Product Picture
Figure 7. Global Inhaled Nitric Oxide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Inhaled Nitric Oxide Sales Market Share by Application in 2024 & 2031
Figure 9. Near-term and Pre-term Infants PPHN
Figure 10. Children and Adult ARDS
Figure 11. Other Diseases
Figure 12. Inhaled Nitric Oxide Report Years Considered
Figure 13. Global Inhaled Nitric Oxide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Inhaled Nitric Oxide Market Size 2020-2031 (US$ Million)
Figure 15. Global Inhaled Nitric Oxide Sales 2020-2031 (M L)
Figure 16. Global Inhaled Nitric Oxide Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Inhaled Nitric Oxide Revenue Market Share by Region (2020-2031)
Figure 18. Global Inhaled Nitric Oxide Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Inhaled Nitric Oxide Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Inhaled Nitric Oxide Average Selling Price (ASP) by Type (2020-2025) & (US$/L)
Figure 21. Global Inhaled Nitric Oxide Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Inhaled Nitric Oxide Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Inhaled Nitric Oxide Average Selling Price (ASP) by Application (2020-2025) & (US$/L)
Figure 24. 800 ppm of Inhaled Nitric Oxide Revenue Market Share by Application, 2024 VS 2031
Figure 25. 100 ppm of Inhaled Nitric Oxide Revenue Market Share by Application, 2024 VS 2031
Figure 26. Others of Inhaled Nitric Oxide Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Inhaled Nitric Oxide Sales Share by Manufacturer in 2024
Figure 28. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. 800 ppm Market Sales Proportion by Manufacturer in 2024
Figure 30. 100 ppm Market Sales Proportion by Manufacturer in 2024
Figure 31. Others Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Inhaled Nitric Oxide Revenue 2020-2031 (US$ Million)
Figure 33. North America Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 34. North America Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Inhaled Nitric Oxide Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Inhaled Nitric Oxide Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Inhaled Nitric Oxide Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 40. Europe Inhaled Nitric Oxide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 42. Europe Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 43. Europe Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 44. Europe Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 45. Latin America Inhaled Nitric Oxide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 47. Latin America Inhaled Nitric Oxide Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 49. Latin America Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Inhaled Nitric Oxide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 55. Inhaled Nitric Oxide Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Inhaled Nitric Oxide Raw Materials by Region in 2024
Figure 57. Inhaled Nitric Oxide Distribution Channels
Figure 58. Global Inhaled Nitric Oxide Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Inhaled Nitric Oxide Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Inhaled Nitric Oxide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Inhaled Nitric Oxide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Inhaled Nitric Oxide Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 5. Global Inhaled Nitric Oxide Sales Forecast by Region (2026-2031) & (M L)
Table 6. Global Inhaled Nitric Oxide Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Inhaled Nitric Oxide Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Inhaled Nitric Oxide Sales Volume by Type (2020-2025) & (M L)
Table 9. Global Inhaled Nitric Oxide Sales Volume by Type (2026-2031) & (M L)
Table 10. Global Inhaled Nitric Oxide Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Inhaled Nitric Oxide Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Inhaled Nitric Oxide Sales Volume by Application (2020-2025) & (M L)
Table 13. Global Inhaled Nitric Oxide Sales Volume by Application (2026-2031) & (M L)
Table 14. Global Inhaled Nitric Oxide Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Inhaled Nitric Oxide Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Inhaled Nitric Oxide Sales by Manufacturer (2020-2025) & (M L)
Table 17. Global Inhaled Nitric Oxide Sales Share by Manufacturer (2020-2025)
Table 18. Inhaled Nitric Oxide Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Inhaled Nitric Oxide Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Inhaled Nitric Oxide Price (2020-2025) & (US$/L)
Table 21. Ranking of Global Top Inhaled Nitric Oxide Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Inhaled Nitric Oxide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Inhaled Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
Table 24. Inhaled Nitric Oxide Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Inhaled Nitric Oxide Market
Table 26. Manufacturers Inhaled Nitric Oxide Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Mallinckrodt Company Information
Table 29. Mallinckrodt Description and Business Overview
Table 30. Mallinckrodt Inhaled Nitric Oxide Product
Table 31. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 32. Mallinckrodt Sales Proportion of Inhaled Nitric Oxide by Product in 2024
Table 33. Mallinckrodt Sales Proportion of Inhaled Nitric Oxide by Application in 2024
Table 34. Mallinckrodt Sales Proportion of Inhaled Nitric Oxide by Geographic Area in 2024
Table 35. Mallinckrodt Recent Developments
Table 36. Praxair (Linde plc) Company Information
Table 37. Praxair (Linde plc) Description and Business Overview
Table 38. Praxair (Linde plc) Inhaled Nitric Oxide Product
Table 39. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 40. Praxair (Linde plc) Sales Proportion of Inhaled Nitric Oxide by Product in 2024
Table 41. Praxair (Linde plc) Sales Proportion of Inhaled Nitric Oxide by Application in 2024
Table 42. Praxair (Linde plc) Sales Proportion of Inhaled Nitric Oxide by Geographic Area in 2024
Table 43. Praxair (Linde plc) Recent Developments
Table 44. Air Liquide Company Information
Table 45. Air Liquide Description and Business Overview
Table 46. Air Liquide Inhaled Nitric Oxide Product
Table 47. Air Liquide Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 48. Air Liquide Sales Proportion of Inhaled Nitric Oxide by Product in 2024
Table 49. Air Liquide Sales Proportion of Inhaled Nitric Oxide by Application in 2024
Table 50. Air Liquide Sales Proportion of Inhaled Nitric Oxide by Geographic Area in 2024
Table 51. Air Liquide Recent Developments
Table 52. BOC Healthcare (Linde Group) Company Information
Table 53. BOC Healthcare (Linde Group) Description and Business Overview
Table 54. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product
Table 55. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 56. BOC Healthcare (Linde Group) Sales Proportion of Inhaled Nitric Oxide by Product in 2024
Table 57. BOC Healthcare (Linde Group) Sales Proportion of Inhaled Nitric Oxide by Application in 2024
Table 58. BOC Healthcare (Linde Group) Sales Proportion of Inhaled Nitric Oxide by Geographic Area in 2024
Table 59. BOC Healthcare (Linde Group) Recent Developments
Table 60. North America Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 61. North America Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 62. North America Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 63. North America Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 64. North America Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 65. North America Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 66. Asia-Pacific Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 67. Asia-Pacific Inhaled Nitric Oxide Sales by Region (2026-2031) & (M L)
Table 68. Asia-Pacific Inhaled Nitric Oxide Revenue by Region (2020-2025) & (US$ Million)
Table 69. Asia-Pacific Inhaled Nitric Oxide Revenue by Region (2026-2031) & (US$ Million)
Table 70. Asia-Pacific Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 71. Asia-Pacific Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 72. Europe Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 73. Europe Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 74. Europe Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 75. Europe Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 76. Europe Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 77. Europe Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 78. Latin America Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 79. Latin America Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 80. Latin America Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 81. Latin America Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 82. Latin America Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 83. Latin America Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 84. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 85. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 86. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 87. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 88. Middle East and Africa Inhaled Nitric Oxide Sales by Type (2020-2025) & (M L)
Table 89. Middle East and Africa Inhaled Nitric Oxide Sales by Application (2020-2025) & (M L)
Table 90. Inhaled Nitric Oxide Key Raw Materials, Industry Status and Trend
Table 91. Inhaled Nitric Oxide Key Raw Materials and Upstream Suppliers
Table 92. Inhaled Nitric Oxide Clients Status and Trend
Table 93. Inhaled Nitric Oxide Typical Clients
Table 94. Inhaled Nitric Oxide Distributors
Table 95. Inhaled Nitric Oxide Market Trends
Table 96. Inhaled Nitric Oxide Market Drivers
Table 97. Inhaled Nitric Oxide Market Challenges
Table 98. Inhaled Nitric Oxide Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Inhaled Nitric Oxide Product Picture
Figure 2. Global Inhaled Nitric Oxide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Inhaled Nitric Oxide Sales Market Share by Type in 2024 & 2031
Figure 4. 800 ppm Product Picture
Figure 5. 100 ppm Product Picture
Figure 6. Others Product Picture
Figure 7. Global Inhaled Nitric Oxide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Inhaled Nitric Oxide Sales Market Share by Application in 2024 & 2031
Figure 9. Near-term and Pre-term Infants PPHN
Figure 10. Children and Adult ARDS
Figure 11. Other Diseases
Figure 12. Inhaled Nitric Oxide Report Years Considered
Figure 13. Global Inhaled Nitric Oxide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Inhaled Nitric Oxide Market Size 2020-2031 (US$ Million)
Figure 15. Global Inhaled Nitric Oxide Sales 2020-2031 (M L)
Figure 16. Global Inhaled Nitric Oxide Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Inhaled Nitric Oxide Revenue Market Share by Region (2020-2031)
Figure 18. Global Inhaled Nitric Oxide Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Inhaled Nitric Oxide Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Inhaled Nitric Oxide Average Selling Price (ASP) by Type (2020-2025) & (US$/L)
Figure 21. Global Inhaled Nitric Oxide Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Inhaled Nitric Oxide Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Inhaled Nitric Oxide Average Selling Price (ASP) by Application (2020-2025) & (US$/L)
Figure 24. 800 ppm of Inhaled Nitric Oxide Revenue Market Share by Application, 2024 VS 2031
Figure 25. 100 ppm of Inhaled Nitric Oxide Revenue Market Share by Application, 2024 VS 2031
Figure 26. Others of Inhaled Nitric Oxide Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Inhaled Nitric Oxide Sales Share by Manufacturer in 2024
Figure 28. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. 800 ppm Market Sales Proportion by Manufacturer in 2024
Figure 30. 100 ppm Market Sales Proportion by Manufacturer in 2024
Figure 31. Others Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Inhaled Nitric Oxide Revenue 2020-2031 (US$ Million)
Figure 33. North America Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 34. North America Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Inhaled Nitric Oxide Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Inhaled Nitric Oxide Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Inhaled Nitric Oxide Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 40. Europe Inhaled Nitric Oxide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 42. Europe Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 43. Europe Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 44. Europe Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 45. Latin America Inhaled Nitric Oxide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 47. Latin America Inhaled Nitric Oxide Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 49. Latin America Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Inhaled Nitric Oxide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Figure 55. Inhaled Nitric Oxide Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Inhaled Nitric Oxide Raw Materials by Region in 2024
Figure 57. Inhaled Nitric Oxide Distribution Channels
Figure 58. Global Inhaled Nitric Oxide Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Inhaled Nitric Oxide Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232